nodes	percent_of_prediction	percent_of_DWPC	metapath
Erlotinib—LTK—tongue—periodontitis	0.0646	0.134	CbGeAlD
Erlotinib—LTK—mouth—periodontitis	0.0435	0.09	CbGeAlD
Erlotinib—ULK3—tongue—periodontitis	0.0351	0.0728	CbGeAlD
Erlotinib—ORM1—saliva—periodontitis	0.0351	0.0727	CbGeAlD
Erlotinib—ULK3—mouth—periodontitis	0.0236	0.0489	CbGeAlD
Erlotinib—TNK1—trigeminal ganglion—periodontitis	0.0235	0.0488	CbGeAlD
Erlotinib—JAK3—connective tissue—periodontitis	0.0213	0.0441	CbGeAlD
Erlotinib—PIP4K2C—trigeminal ganglion—periodontitis	0.0183	0.0378	CbGeAlD
Erlotinib—ULK3—trigeminal ganglion—periodontitis	0.0174	0.0361	CbGeAlD
Erlotinib—PIP4K2C—parotid gland—periodontitis	0.0172	0.0357	CbGeAlD
Erlotinib—FLT3—connective tissue—periodontitis	0.0168	0.0348	CbGeAlD
Erlotinib—ULK3—parotid gland—periodontitis	0.0165	0.0341	CbGeAlD
Erlotinib—MKNK1—trigeminal ganglion—periodontitis	0.0164	0.034	CbGeAlD
Erlotinib—SLK—trigeminal ganglion—periodontitis	0.0156	0.0322	CbGeAlD
Erlotinib—SLK—parotid gland—periodontitis	0.0147	0.0304	CbGeAlD
Erlotinib—STK10—trigeminal ganglion—periodontitis	0.0135	0.028	CbGeAlD
Erlotinib—MAP2K5—trigeminal ganglion—periodontitis	0.0121	0.025	CbGeAlD
Erlotinib—MAP2K5—parotid gland—periodontitis	0.0114	0.0236	CbGeAlD
Erlotinib—ABL1—trigeminal ganglion—periodontitis	0.00932	0.0193	CbGeAlD
Erlotinib—ABL1—parotid gland—periodontitis	0.00879	0.0182	CbGeAlD
Erlotinib—ABL1—connective tissue—periodontitis	0.00773	0.016	CbGeAlD
Erlotinib—CYP1A1—mouth—periodontitis	0.00755	0.0156	CbGeAlD
Erlotinib—CYP1B1—connective tissue—periodontitis	0.00655	0.0136	CbGeAlD
Erlotinib—ABCG2—trigeminal ganglion—periodontitis	0.00587	0.0122	CbGeAlD
Erlotinib—ABCG2—parotid gland—periodontitis	0.00554	0.0115	CbGeAlD
Erlotinib—CYP1A1—parotid gland—periodontitis	0.00526	0.0109	CbGeAlD
Erlotinib—CYP1A1—epithelium—periodontitis	0.00439	0.0091	CbGeAlD
Erlotinib—ABCB1—trigeminal ganglion—periodontitis	0.0029	0.006	CbGeAlD
Erlotinib—ABCB1—epithelium—periodontitis	0.00228	0.00473	CbGeAlD
Erlotinib—EGFR—Adaptive Immune System—CD79A—periodontitis	0.000297	0.000575	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—CD14—periodontitis	0.000297	0.000574	CbGpPWpGaD
Erlotinib—EGFR—Disease—ACP5—periodontitis	0.000296	0.000572	CbGpPWpGaD
Erlotinib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—periodontitis	0.000293	0.000566	CbGpPWpGaD
Erlotinib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—periodontitis	0.000293	0.000566	CbGpPWpGaD
Erlotinib—ABL1—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	0.000292	0.000564	CbGpPWpGaD
Erlotinib—ABL2—Developmental Biology—IL6—periodontitis	0.000291	0.000562	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—CXCR2—periodontitis	0.00029	0.000561	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—PPARA—periodontitis	0.00029	0.000561	CbGpPWpGaD
Erlotinib—ALB—Platelet degranulation—TGFB1—periodontitis	0.000288	0.000557	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—AGER—periodontitis	0.000285	0.000551	CbGpPWpGaD
Erlotinib—JAK3—Immune System—CRP—periodontitis	0.000283	0.000546	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—SLC52A3—periodontitis	0.000281	0.000543	CbGpPWpGaD
Erlotinib—ABL1—Hemostasis—MMP1—periodontitis	0.000279	0.000539	CbGpPWpGaD
Erlotinib—ABL1—Immune System—FCGR2A—periodontitis	0.000278	0.000538	CbGpPWpGaD
Erlotinib—EGFR—Signaling by NGF—FGF2—periodontitis	0.000277	0.000535	CbGpPWpGaD
Erlotinib—EGFR—MAPK Signaling Pathway—TGFB1—periodontitis	0.000276	0.000534	CbGpPWpGaD
Erlotinib—EGFR—Spinal Cord Injury—IL6—periodontitis	0.000276	0.000534	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—VCAM1—periodontitis	0.000275	0.000532	CbGpPWpGaD
Erlotinib—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—periodontitis	0.000274	0.00053	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—ACP5—periodontitis	0.000272	0.000527	CbGpPWpGaD
Erlotinib—ABL1—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	0.000272	0.000526	CbGpPWpGaD
Erlotinib—JAK3—Immune System—TLR4—periodontitis	0.000271	0.000524	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CXCL3—periodontitis	0.000266	0.000515	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—SLC52A3—periodontitis	0.000265	0.000513	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—MET—periodontitis	0.000264	0.00051	CbGpPWpGaD
Erlotinib—EGFR—Axon guidance—MMP2—periodontitis	0.000263	0.000509	CbGpPWpGaD
Erlotinib—JAK3—Hemostasis—TGFB1—periodontitis	0.000261	0.000505	CbGpPWpGaD
Erlotinib—EGFR—MAPK Signaling Pathway—TNF—periodontitis	0.000258	0.000498	CbGpPWpGaD
Erlotinib—MKNK1—Disease—FGF2—periodontitis	0.000257	0.000497	CbGpPWpGaD
Erlotinib—ABCB1—Allograft Rejection—TGFB1—periodontitis	0.000255	0.000493	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—CCL2—periodontitis	0.000254	0.000492	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—ACP5—periodontitis	0.000254	0.000491	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling by NGF—IL6—periodontitis	0.000253	0.00049	CbGpPWpGaD
Erlotinib—ALB—Folate Metabolism—IL6—periodontitis	0.000253	0.000489	CbGpPWpGaD
Erlotinib—ABL1—Hemostasis—NOS2—periodontitis	0.000252	0.000486	CbGpPWpGaD
Erlotinib—CYP3A4—Biological oxidations—GGT1—periodontitis	0.00025	0.000484	CbGpPWpGaD
Erlotinib—EGFR—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	0.000249	0.000482	CbGpPWpGaD
Erlotinib—ALB—Selenium Micronutrient Network—TNF—periodontitis	0.000249	0.000482	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—CCR2—periodontitis	0.000249	0.000481	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—NTRK1—periodontitis	0.000249	0.000481	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—CRP—periodontitis	0.000248	0.00048	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—PPARA—periodontitis	0.000248	0.000479	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—ADRB1—periodontitis	0.000247	0.000478	CbGpPWpGaD
Erlotinib—EPHA6—Developmental Biology—IL6—periodontitis	0.000245	0.000474	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—AGER—periodontitis	0.000243	0.000471	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—SLC52A3—periodontitis	0.000243	0.000471	CbGpPWpGaD
Erlotinib—ALB—Metabolism—SLC52A3—periodontitis	0.000242	0.000468	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CCR2—periodontitis	0.000241	0.000467	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IL1RN—periodontitis	0.00024	0.000465	CbGpPWpGaD
Erlotinib—EGFR—Signaling by SCF-KIT—IL6—periodontitis	0.000239	0.000463	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—TLR4—periodontitis	0.000238	0.00046	CbGpPWpGaD
Erlotinib—EGFR—Immune System—FCGR2A—periodontitis	0.000238	0.00046	CbGpPWpGaD
Erlotinib—ABCB1—Allograft Rejection—TNF—periodontitis	0.000238	0.00046	CbGpPWpGaD
Erlotinib—EGFR—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	0.000233	0.00045	CbGpPWpGaD
Erlotinib—MKNK1—Disease—PTGS2—periodontitis	0.000232	0.000448	CbGpPWpGaD
Erlotinib—ABL1—Axon guidance—MMP9—periodontitis	0.000232	0.000448	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—ACP5—periodontitis	0.000231	0.000447	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—MMP3—periodontitis	0.000231	0.000447	CbGpPWpGaD
Erlotinib—EGFR—Downstream signaling of activated FGFR—IL6—periodontitis	0.000229	0.000443	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism of lipids and lipoproteins—PPARA—periodontitis	0.000227	0.000439	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—CCR2—periodontitis	0.000226	0.000437	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—MET—periodontitis	0.000225	0.000436	CbGpPWpGaD
Erlotinib—EGFR—Signaling by ERBB4—IL6—periodontitis	0.000225	0.000436	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—ADRB1—periodontitis	0.000225	0.000435	CbGpPWpGaD
Erlotinib—ABL1—Immune System—TLR2—periodontitis	0.000224	0.000434	CbGpPWpGaD
Erlotinib—JAK3—GPCR downstream signaling—CXCL8—periodontitis	0.000221	0.000428	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—TIMP1—periodontitis	0.000221	0.000427	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—MMP2—periodontitis	0.00022	0.000425	CbGpPWpGaD
Erlotinib—EGFR—Downstream signal transduction—IL6—periodontitis	0.000215	0.000416	CbGpPWpGaD
Erlotinib—EGFR—Signaling by FGFR—IL6—periodontitis	0.000214	0.000414	CbGpPWpGaD
Erlotinib—EGFR—Signaling by ERBB2—IL6—periodontitis	0.000213	0.000412	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—CRP—periodontitis	0.000212	0.00041	CbGpPWpGaD
Erlotinib—EGFR—DAP12 signaling—IL6—periodontitis	0.000212	0.00041	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—SLC52A3—periodontitis	0.000212	0.00041	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CD79A—periodontitis	0.000211	0.000408	CbGpPWpGaD
Erlotinib—JAK3—Immune System—FGF2—periodontitis	0.00021	0.000406	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—FGF2—periodontitis	0.000209	0.000404	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CCR2—periodontitis	0.000206	0.000399	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IL1RN—periodontitis	0.000205	0.000397	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—TLR4—periodontitis	0.000203	0.000393	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—NTRK1—periodontitis	0.000203	0.000392	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CD14—periodontitis	0.000202	0.000391	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—CXCL8—periodontitis	0.000201	0.000389	CbGpPWpGaD
Erlotinib—ALB—Selenium Micronutrient Network—IL6—periodontitis	0.000201	0.000389	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—SLC52A3—periodontitis	0.0002	0.000386	CbGpPWpGaD
Erlotinib—EGFR—Fc epsilon receptor (FCERI) signaling—IL6—periodontitis	0.000199	0.000386	CbGpPWpGaD
Erlotinib—EGFR—DAP12 interactions—IL6—periodontitis	0.000199	0.000386	CbGpPWpGaD
Erlotinib—EGFR—Signaling by FGFR in disease—IL6—periodontitis	0.000199	0.000386	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—CCL2—periodontitis	0.000199	0.000385	CbGpPWpGaD
Erlotinib—EGFR—Axon guidance—MMP9—periodontitis	0.000198	0.000383	CbGpPWpGaD
Erlotinib—EGFR—Signaling by EGFR—IL6—periodontitis	0.000198	0.000382	CbGpPWpGaD
Erlotinib—JAK3—Immune System—IFNG—periodontitis	0.000198	0.000382	CbGpPWpGaD
Erlotinib—ABCG2—Transmembrane transport of small molecules—PPARA—periodontitis	0.000196	0.00038	CbGpPWpGaD
Erlotinib—EGFR—Signaling by EGFR in Cancer—IL6—periodontitis	0.000196	0.000379	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—GGT1—periodontitis	0.000195	0.000378	CbGpPWpGaD
Erlotinib—ABL1—Immune System—VCAM1—periodontitis	0.000195	0.000378	CbGpPWpGaD
Erlotinib—EGFR—Signaling by PDGF—IL6—periodontitis	0.000195	0.000377	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—periodontitis	0.000193	0.000373	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—VIP—periodontitis	0.000192	0.000372	CbGpPWpGaD
Erlotinib—EGFR—Immune System—TLR2—periodontitis	0.000192	0.000371	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—MMP3—periodontitis	0.000188	0.000364	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—MMP2—periodontitis	0.000188	0.000364	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—FGF2—periodontitis	0.000185	0.000357	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CD79A—periodontitis	0.00018	0.000349	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—FGF2—periodontitis	0.00018	0.000348	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—periodontitis	0.000179	0.000346	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—FGF2—periodontitis	0.000179	0.000345	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—GGT1—periodontitis	0.000178	0.000344	CbGpPWpGaD
Erlotinib—EGFR—NGF signalling via TRKA from the plasma membrane—IL6—periodontitis	0.000177	0.000342	CbGpPWpGaD
Erlotinib—JAK3—Immune System—IL1B—periodontitis	0.000176	0.000341	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—periodontitis	0.000174	0.000336	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IL1A—periodontitis	0.000173	0.000335	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CD14—periodontitis	0.000173	0.000334	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IL18—periodontitis	0.000173	0.000334	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CXCR2—periodontitis	0.000172	0.000332	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—MMP3—periodontitis	0.000171	0.000331	CbGpPWpGaD
Erlotinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—periodontitis	0.000171	0.00033	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—SLC52A3—periodontitis	0.000169	0.000327	CbGpPWpGaD
Erlotinib—MKNK1—Disease—TGFB1—periodontitis	0.000168	0.000324	CbGpPWpGaD
Erlotinib—EGFR—Immune System—VCAM1—periodontitis	0.000167	0.000323	CbGpPWpGaD
Erlotinib—ABL1—Immune System—AGER—periodontitis	0.000166	0.000321	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—ACP5—periodontitis	0.000166	0.00032	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—MMP9—periodontitis	0.000165	0.00032	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—FGF2—periodontitis	0.000158	0.000305	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—CXCL8—periodontitis	0.000158	0.000305	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—ACP5—periodontitis	0.000156	0.000302	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—GGT1—periodontitis	0.000151	0.000293	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—FGF2—periodontitis	0.000151	0.000293	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—CCL2—periodontitis	0.00015	0.000291	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IL1A—periodontitis	0.000148	0.000286	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	0.000148	0.000285	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IL18—periodontitis	0.000148	0.000285	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CRP—periodontitis	0.000145	0.00028	CbGpPWpGaD
Erlotinib—ABL1—Axon guidance—IL6—periodontitis	0.000144	0.000278	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—ACP5—periodontitis	0.000143	0.000277	CbGpPWpGaD
Erlotinib—ALB—Metabolism—ACP5—periodontitis	0.000143	0.000276	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—MMP9—periodontitis	0.000142	0.000275	CbGpPWpGaD
Erlotinib—EGFR—Immune System—AGER—periodontitis	0.000142	0.000274	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—MMP9—periodontitis	0.000141	0.000273	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—GGT1—periodontitis	0.000141	0.000273	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—periodontitis	0.00014	0.00027	CbGpPWpGaD
Erlotinib—ABL1—Immune System—TLR4—periodontitis	0.000139	0.000268	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—MMP1—periodontitis	0.000137	0.000266	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—TGFB1—periodontitis	0.000136	0.000264	CbGpPWpGaD
Erlotinib—EGFR—Signaling by NGF—IL6—periodontitis	0.000136	0.000263	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—FGF2—periodontitis	0.000136	0.000263	CbGpPWpGaD
Erlotinib—ABL1—Hemostasis—TGFB1—periodontitis	0.000134	0.000259	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CCR2—periodontitis	0.000133	0.000258	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—ADRB1—periodontitis	0.000133	0.000257	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—SLC52A3—periodontitis	0.000131	0.000253	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—GGT1—periodontitis	0.000129	0.000249	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—periodontitis	0.000128	0.000248	CbGpPWpGaD
Erlotinib—ALB—Platelet activation, signaling and aggregation—TGFB1—periodontitis	0.000128	0.000247	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—PPARA—periodontitis	0.000127	0.000246	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—TNF—periodontitis	0.000127	0.000246	CbGpPWpGaD
Erlotinib—MKNK1—Disease—IL6—periodontitis	0.000126	0.000244	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	0.000126	0.000243	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—ACP5—periodontitis	0.000125	0.000242	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—periodontitis	0.000125	0.000241	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—NOS2—periodontitis	0.000124	0.000239	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CRP—periodontitis	0.000124	0.000239	CbGpPWpGaD
Erlotinib—EGFR—Axon guidance—IL6—periodontitis	0.000123	0.000238	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—CCL2—periodontitis	0.000122	0.000237	CbGpPWpGaD
Erlotinib—ALB—Transmembrane transport of small molecules—PPARA—periodontitis	0.000121	0.000234	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—CXCL8—periodontitis	0.000119	0.00023	CbGpPWpGaD
Erlotinib—EGFR—Immune System—TLR4—periodontitis	0.000118	0.000229	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—ACP5—periodontitis	0.000118	0.000228	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—TGFB1—periodontitis	0.000117	0.000227	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	0.000117	0.000227	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—TGFB1—periodontitis	0.000116	0.000225	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—IL6—periodontitis	0.000113	0.000218	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—CCL2—periodontitis	0.000111	0.000215	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—FGF2—periodontitis	0.000111	0.000214	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—TNF—periodontitis	0.000109	0.00021	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—NTRK1—periodontitis	0.000109	0.00021	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—PPARA—periodontitis	0.000108	0.00021	CbGpPWpGaD
Erlotinib—ABL1—Immune System—FGF2—periodontitis	0.000108	0.000208	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—MMP9—periodontitis	0.000107	0.000208	CbGpPWpGaD
Erlotinib—ABCB1—Transmembrane transport of small molecules—PPARA—periodontitis	0.000106	0.000205	CbGpPWpGaD
Erlotinib—EGFR—Disease—NOS2—periodontitis	0.000104	0.000201	CbGpPWpGaD
Erlotinib—JAK3—Immune System—IL6—periodontitis	0.000103	0.0002	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—IL6—periodontitis	0.000103	0.000199	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IFNG—periodontitis	0.000101	0.000196	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—PPARA—periodontitis	0.000101	0.000196	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—MMP3—periodontitis	0.000101	0.000195	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—ACP5—periodontitis	9.97e-05	0.000193	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—CXCL8—periodontitis	9.68e-05	0.000187	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—GGT1—periodontitis	9.21e-05	0.000178	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—PPARA—periodontitis	9.2e-05	0.000178	CbGpPWpGaD
Erlotinib—EGFR—Immune System—FGF2—periodontitis	9.19e-05	0.000178	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	9.09e-05	0.000176	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—IL6—periodontitis	9.07e-05	0.000175	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IL1B—periodontitis	9.02e-05	0.000174	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—periodontitis	8.92e-05	0.000172	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—TGFB1—periodontitis	8.85e-05	0.000171	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—IL6—periodontitis	8.85e-05	0.000171	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—CXCL8—periodontitis	8.8e-05	0.00017	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—IL6—periodontitis	8.78e-05	0.00017	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—MMP9—periodontitis	8.76e-05	0.000169	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—GGT1—periodontitis	8.7e-05	0.000168	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IFNG—periodontitis	8.64e-05	0.000167	CbGpPWpGaD
Erlotinib—EGFR—Disease—FGF2—periodontitis	8.48e-05	0.000164	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	8.34e-05	0.000161	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	8.29e-05	0.00016	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—GGT1—periodontitis	7.98e-05	0.000154	CbGpPWpGaD
Erlotinib—ALB—Metabolism—GGT1—periodontitis	7.93e-05	0.000153	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—IL6—periodontitis	7.75e-05	0.00015	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IL1B—periodontitis	7.71e-05	0.000149	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ACP5—periodontitis	7.7e-05	0.000149	CbGpPWpGaD
Erlotinib—EGFR—Disease—PTGS2—periodontitis	7.65e-05	0.000148	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—TGFB1—periodontitis	7.22e-05	0.00014	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—PTGS2—periodontitis	7.05e-05	0.000136	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—GGT1—periodontitis	6.95e-05	0.000134	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—IL6—periodontitis	6.67e-05	0.000129	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PPARA—periodontitis	6.59e-05	0.000127	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—TGFB1—periodontitis	6.58e-05	0.000127	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—PTGS2—periodontitis	6.58e-05	0.000127	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CCL2—periodontitis	6.57e-05	0.000127	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—GGT1—periodontitis	6.55e-05	0.000127	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PPARA—periodontitis	6.23e-05	0.00012	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—PTGS2—periodontitis	5.98e-05	0.000116	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—FGF2—periodontitis	5.94e-05	0.000115	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	5.8e-05	0.000112	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PPARA—periodontitis	5.71e-05	0.00011	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PPARA—periodontitis	5.68e-05	0.00011	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—GGT1—periodontitis	5.55e-05	0.000107	CbGpPWpGaD
Erlotinib—EGFR—Disease—TGFB1—periodontitis	5.53e-05	0.000107	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—IL6—periodontitis	5.44e-05	0.000105	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IL6—periodontitis	5.28e-05	0.000102	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CXCL8—periodontitis	5.2e-05	0.0001	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PPARA—periodontitis	4.97e-05	9.62e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—IL6—periodontitis	4.94e-05	9.55e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—MMP9—periodontitis	4.7e-05	9.09e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PPARA—periodontitis	4.69e-05	9.06e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IL6—periodontitis	4.51e-05	8.73e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PTGS2—periodontitis	4.29e-05	8.29e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GGT1—periodontitis	4.28e-05	8.28e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—IL6—periodontitis	4.17e-05	8.06e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PTGS2—periodontitis	4.05e-05	7.83e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PPARA—periodontitis	3.97e-05	7.68e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—TGFB1—periodontitis	3.87e-05	7.49e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PTGS2—periodontitis	3.71e-05	7.18e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PTGS2—periodontitis	3.69e-05	7.14e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PTGS2—periodontitis	3.23e-05	6.25e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PPARA—periodontitis	3.06e-05	5.93e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PTGS2—periodontitis	3.05e-05	5.89e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—IL6—periodontitis	2.92e-05	5.64e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PTGS2—periodontitis	2.58e-05	4.99e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PTGS2—periodontitis	1.99e-05	3.85e-05	CbGpPWpGaD
